Skip to main content

Advertisement

Log in

Pathogenesis of Cryptococcus neoformans is Associated with Quantitative Differences in Multiple Virulence Factors

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Two isolates of Cryptococcus neoformans were previously described as being highly divergent in their level of capsule synthesis in vivo and in their virulence for mice. The highly virulent isolate (NU-2) produced more capsule than a weakly virulent isolate (184A) in vitro under tissue culture conditions and in vivo. This investigation was done to determine if there were differences between the two isolates in other factors that might also contribute to virulence. Growth rate was not a factor as NU-2 grew more slowly than 184A. Based on PCR fingerprinting the two isolates were genetically different providing an opportunity to examine differences in multiple virulence traits. Quantitative analysis revealed that NU-2 expressed significantly more melanin and mannitol than did 184A. Although the isolates expressed the same capsular chemotype, NU-2 produced an additional structure reporter group (SRG)under tissue culture conditions that was not present when grown in glucose salts/urea/basal medium (GSU).Capsular polysaccharide SRGs of 184A were unaffected by shifting the growth conditions from GSU to tissue culture conditions. Our results suggest that pathogenesis of a C. neoformans strain is dictated by the quantitative expression of the strain's combined virulence traits. Regulators of the expression of these genes may be playing key roles in virulence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. American Journal of Epidemiology 1984; 120: 123–130.

    Google Scholar 

  2. Kwon-Chung KJ, Bennett JE. Cryptococcosis. Medical Mycology. Philadelphia, PA: Lea & Febiger, 1992: 398–399.

    Google Scholar 

  3. Blackstock R, Murphy JW. Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans. Infection and Immunity 1997; 65: 4114–4121.

    Google Scholar 

  4. Curtis JL, Huffnagle GB, Chen GH et al. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Laboratory Investigation 1994; 71: 113–126.

    Google Scholar 

  5. Blackstock R, Buchanan KL, Adesina AM, Murphy JW. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infection and Immunity 1999; 67: 3601–3609.

    Google Scholar 

  6. Turner SH, Cherniak R, Reiss E, Kwon Chung KJ. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype-A isolates determined by C-13 NMR spectroscopy. Carbohydrate Research 1992; 233: 205–218.

    Google Scholar 

  7. Buchanan KL, Murphy JW. What makes Cryptococcus neoformans a pathogen? Emerging Infectious Diseases 1998; 4: 71–83.

    Google Scholar 

  8. Dong ZM, Murphy JW. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infection and Immunity 1995; 63: 770–778.

    Google Scholar 

  9. Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. Journal of Clinical Investigation 1996; 97: 689–698.

    Google Scholar 

  10. Dong ZM, Jackson L, Murphy JW. Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan. Infection and Immunity 1999; 67: 220–229.

    Google Scholar 

  11. Murphy JW. Cell-Mediated Immunity. The Mycota Volume VII, Animal and Human Relationships. 1996: 67–97.

  12. Rhodes JC, Polacheck I, Kwon-Chung KJ. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infection and Immunity 1982; 36: 1175–1184.

    Google Scholar 

  13. Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infection and Immunity 1995; 63: 3131–3136.

    Google Scholar 

  14. Huffnagle GB, Strieter RM, NcNeil LS, McDonald RA, Burdick MD, Toews GB. The role of TNF and melanin in modulating the development of protective T cell mediated immunity in the lungs to C. neoformans. Proceedings of the 3rd International Conference on Cryptococcus and Cryptococcosis 1996; 164.

  15. Chaturvedi V, Wong B, Newman SL. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. The Journal of Immunology 1996; 156: 3836–3840.

    Google Scholar 

  16. Wong B, Perfect JR, Beggs S, Wright KA. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infection and Immunity 1990; 58: 1664–1670.

    Google Scholar 

  17. Growth of Bacteria. Sokatch JR, Ferretti JJ. Basic Bacteriology and Genetics. Chicago: Year Book Medical Publishers, 1976: 36–54.

  18. Moore TD, Edman JC. The alpha-mating type locus of Cryptococcus neoformans contains a peptide phermone gene. Molecular and Cellular Biology 1993; 13: 1962–1970.

    Google Scholar 

  19. Meyer W, Mitchell TG. Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: strain variation in Cryptococcus neoformans. Electrophoresis 1995; 16(9): 1648–1656.

    Google Scholar 

  20. Cherniak R, O'Neill EB, Sheng S. Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy. Infection and Immunity 1998; 66: 2996–2998.

    Google Scholar 

  21. Cherniak R, Valafar H, Morris LC, Valafar F. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clinical and Diagnostic Laboratory Immunology 1998; 5: 146–159.

    Google Scholar 

  22. Cherniak R, Morris LC, Meyer SA. Glucuronoxylomannan of Cryptococcus neoformans serotype-C - Structural analysis by gas liquid chromatography mass spectrometry and C-13-nuclear magnetic resonance spectroscopy. Carbohydrate Research 1992; 225: 331–337.

    Google Scholar 

  23. Rhodes JC. A simplified assay for cryptococcal phenoloxidase. Mycologia 1986; 78: 867–868.

    Google Scholar 

  24. Wong B, Brauer L, Tsai RR, Jayasimhulu K. Increased amounts of the Aspergillus metabolite D-mannitol in tissues and serum of animals with experimental aspergillosis. Journal of Infectious Diseases 1989; 160: 95–103.

    Google Scholar 

  25. Kwon-Chung KJ, Edman JC, Wickes BL. Genetic association of mating types and virulence in Cryptococcus neoformans. Infection and Immunity 1992; 60: 602–605.

    Google Scholar 

  26. Fries BC, Casadevall A. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. Journal of Infectious Diseases 1998; 178: 1761–1766.

    Google Scholar 

  27. Huffnagle GB, Chen G-H, Curtis JL, McDonald RA, Strieter RM, Toews GB. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. Journal of Immunology 1995; 155: 3507–3516.

    Google Scholar 

  28. Liu L, Tewari RP, Williamson PR. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infection and Immunity 1999; 67: 6034–6039.

    Google Scholar 

  29. Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES. Regulation of cryptococcal capsular polysaccharide by iron. Journal of Infectious Diseases 1993; 167: 186–190.

    Google Scholar 

  30. Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. Journal of Clinical Investigation 1985; 76: 508–516.

    Google Scholar 

  31. Nurudeen TA, Ahearn DG. Regulation of melanin production by Cryptococcus neoformans. Journal of Clinical Microbiology 1979; 10: 724–729.

    Google Scholar 

  32. Polacheck I, Hearing VJ, Kwon-Chung KJ. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. Journal of Bacteriology 1982; 150: 1212–1220.

    Google Scholar 

  33. Williamson PR. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: iden11 tification as a laccase. Journal of Bacteriology 1994; 176: 656–664.

    Google Scholar 

  34. Kwon-Chung KJ. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976; 68: 942–946.

    Google Scholar 

  35. Wickes BL, Mayorga ME, Edman U, Edman JC. Dimorphism and hapliod fruiting in Cryptococcus neoformans: Association with the α-mating type. Proceedings of the National Academy of Sciences USA 1996; 93: 7327–7331.

    Google Scholar 

  36. Alspaugh JA, Perfect JR, Heitman J. Cryptococcus neoformans mating and virulence are regulated by the G-protein a subunit GPA1 and cAMP. Genes and Development 1997; 11: 3206–3217.

    Google Scholar 

  37. Lorenz MD, Heitman J. Yeast pseudohyphal growth is regulated by GPA2, a G protein a homolog. EMBO Journal 1997; 16: 7008–7018.

    Google Scholar 

  38. Chaturvedi V, Flynn T, Niehaus T, Wong B. Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans. Microbiology 1996; 142: 937–943.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blackstock, R., Buchanan, K.L., Cherniak, R. et al. Pathogenesis of Cryptococcus neoformans is Associated with Quantitative Differences in Multiple Virulence Factors. Mycopathologia 147, 1–11 (1999). https://doi.org/10.1023/A:1007041401743

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007041401743

Navigation